OTC · Medical - Devices

EKF Diagnostics Holdings plc (EKDHF) Stock

$0.35 +0.00% OTC: EKDHF Healthcare

EKF Diagnostics Holdings plc, a company founded in Cardiff, United Kingdom in 1990, specializes in the global design, development, manufacture, and sale of diagnostic instruments, reagents, and supporting products. Operating across Europe, the Middle East, the Americas, Asia, and Africa, the company offers a comprehensive range of solutions for clinical diagnostics.

Valuation

MetricValue
Price$0.35
Market Cap$149.28M
P/E Ratio54.68
P/B Ratio1.67
P/S Ratio2.14
EPS (TTM)$0.01
52-Week High$0.42
52-Week Low$0.29
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE3.01%
ROA2.62%
ROCE9.15%
Gross Margin51.35%
Operating Margin13.08%
Net Margin4.12%
Debt/Equity0.02
Current Ratio4.16

Annual Financials (USD)

Metric20212022202320242025
Revenue$82.0M$67.0M$53.0M$50.0M$52.0M
Operating Profit$22.0M$2.0M$2.0M$6.0M$7.0M
Net Profit$16.0M$-10.0M$2.0M$6.0M$2.0M
EPS$0.03$-0.02$0.01$0.01$0.00
Op Margin26.6%2.9%4.0%12.9%13.5%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$115.0M$89.0M$81.0M$82.0M$81.0M
Total Liabilities$20.0M$15.0M$13.0M$9.0M$11.0M
Cash$20.0M$12.0M$6.0M$14.0M$16.0M
Borrowings$3.0M$2.0M$4.0M$1.0M$1.0M

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$10.0M$10.0M$6.0M$14.0M$10.0M
Investing Cash Flow$-11.0M$-15.0M$-13.0M$-5.0M$-4.0M
Financing Cash Flow$-1.0M$-5.0M$-1.0M$-1.0M$-6.0M
Net Cash Flow$-2.0M$-9.0M$-4.0M$7.0M$3.0M
Free Cash Flow$5.0M$4.0M$-1.0M$11.0M$8.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-0.83
EV / EBITDA7.80
FCF Yield7.39%
Quick Ratio3.04
Interest Coverage43.81
Return 1Y-0.89%
Return 3Y15.21%
Return 5Y—

Ownership

Insiders Held1.18%
Institutions Held73.89%
Institutions Float Held74.77%
Institutional HolderSharesReport Date
iShares Trust-iShares International Small-Cap Equity Factor ETF524,9712026-06-30
DFA INVESTMENT TRUST CO-The United Kingdom Small Company Series79,3842026-04-30
DFA INVESTMENT DIMENSIONS GROUP INC-Intl Sustainability Core 1 PORT.91,0502026-04-30
Brighthouse Fd.s TRT II-Brighthouse/Dimensional Intl Small Company POR38,0202026-03-31
DFA INVESTMENT DIMENSIONS GROUP INC-Dimensional VA Intl Small PORT.40,2192026-04-30

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ADOCYAdocia S.A. $11.80 +0.00% -3.91 $170.44M 0.00%
AMCY $3.00 -40.00% — $171.27M 0.00%
AMEUFAnteris Technologies Ltd $5.70 -35.81% -3.37 $120.50M 0.00%
AMGXFAnGes, Inc. $0.36 +0.00% -3.40 $142.50M 0.00%
BRNHFBroncus Holding Corporation $0.08 +0.00% -2.21 $42.13M 0.00%

About EKF Diagnostics Holdings plc

EKF Diagnostics Holdings plc, a company founded in Cardiff, United Kingdom in 1990, specializes in the global design, development, manufacture, and sale of diagnostic instruments, reagents, and supporting products. Operating across Europe, the Middle East, the Americas, Asia, and Africa, the company offers a comprehensive range of solutions for clinical diagnostics. Their product line encompasses various diagnostic tools, including hemoglobin analyzers such as the hand-held DiaSpect Tm, DiaSpect Hemoglobin T, and the lab-quality Hemo Control, alongside the HemataStat II microhematocrit centrifuge. For diabetes management and monitoring, EKF provides glycated hemoglobin analyzers like Quo-Lab A1c and Quo-Test A1c, in addition to glucose and lactate analyzers such as the Biosen C-Line GP+, C-Line Clinic, and Lactate Scout 4. The company also manufactures specialized analyzers, including the STAT-Site M Beta-hydroxybutyrate analyzer, Creamatocrit Plus for assessing lipid concentration and calorific density in mothers' milk, and pregnancy tests like QuPID and True20. EKF's portfolio extends to clinical chemical analyzers and reagents covering ketosis monitoring (Beta-hydroxybutyrate, Nitro-tab Ketone tablets), Glycated Albumin, Glycated Serum Protein, and Procalcitonin, a marker for bacterial infection and sepsis. Additional offerings include RaPET Serology immunoassay kits, rapid tests like QuStick Strep A for Strep A infections, and various laboratory instruments such as the Altair 240 chemistry analyzer, Excel semi-automated chemistry analyzer, and Micro 12 centrifuge. EKF also supplies Hema-Screen Serology for early colorectal cancer detection, the Uri-Trak 120 urine analyzer, and provides kits and services related to COVID-19. Beyond product sales, the company offers contract manufacturing solutions to third-party businesses and provides laboratory services.

EKF Diagnostics Holdings plc is headquartered in GB.

EKF Diagnostics Holdings plc (EKDHF) stock trades at $0.35 with a market capitalization of $149.28M. The stock is valued at a price-to-earnings (P/E) ratio of 54.68, price-to-book of 1.67, price-to-sales of 2.14. Over the past 52 weeks the stock has ranged between $0.29 and $0.42, and currently trades 16.7% below its 52-week high.

On profitability, EKF Diagnostics Holdings plc generates a return on equity (ROE) of 3.01%, return on capital employed of 9.15%, an operating margin of 13.08%, a net profit margin of 4.12%.

Official website: www.ekfdiagnostics.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides